VC-backed technology company developing and delivering disruptive technologies to boost recombinant biologics production using proprietary technologies based on Baculovirus vector expression systems (BVES) in insect cells. Supported by a first in class Strategic Advisory Board combining investment and operational experience in developing and leading companies in animal and human health. Two proprietary and patented technology ...
VC-backed technology company developing and delivering disruptive technologies to boost recombinant biologics production using proprietary technologies based on Baculovirus vector expression systems (BVES) in insect cells. Supported by a first in class Strategic Advisory Board combining investment and operational experience in developing and leading companies in animal and human health. Two proprietary and patented technology platforms, Top-Bac® and CrisBio®, to respond to industry’s challenges in the production of biologicals: development time, scalability, versatility and cost.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.